logo
ORSL® Expands its Hydration Portfolio, launches ORSL® ZERO Electrolyte Drink for Calorie-Conscious Consumers

ORSL® Expands its Hydration Portfolio, launches ORSL® ZERO Electrolyte Drink for Calorie-Conscious Consumers

Hans India3 days ago
ORSL®, India's #1 Electrolyte Drink today announced the expansion of its electrolyte and hydration portfolio with the launch of ORSL® ZERO, an electrolyte drink with zero added sugar and made with real mango pulp. With this launch, Kenvue with its brand ORSL® reinforces its commitment to providing a holistic science-backed portfolio of hydration solutions that help meet the evolving and varied needs of Indian consumers.
Crafted for everyday wellness, ORSL® ZERO Mango Electrolyte Drink combines three vital electrolytes with real mango pulp and zero added sugar offering hydration that is both tasty and guilt free.
The new ORSL® ZERO Mango Electrolyte Drink addresses a critical gap in the hydration space offering optimal hydration with zero added sugar and great taste for diverse consumers who love nutritious indulgence. The minimal amount of calories in ORSL® Zero Electrolyte Drink are from naturally occurring sugars of mango pulp. Suitable for individuals who are calorie conscious and careful about sugar intake as part of lifestyle wellness, ORSL® ZERO Electrolyte Drink Mango eliminates the choice between guilt-free hydration and taste. It provides a delicious way to stay hydrated while helping replenish essential electrolytes for optimal wellness.
ORSL® ZERO Electrolyte Drink also provides an equally viable solution to individuals' following low-carb or keto diets, practicing intermittent fasting, or engaging in regular workouts. These groups are susceptible to electrolyte loss and dehydration due to restrictive diets, intense physical activity, or reduced fluid intake. For them, this solution delivers the perfect bridge between great taste and rehydration.
Commenting on the launch, Prashant Shinde, Business Head – Self-Care, Kenvue India, shared, 'In the recent years, we have seen acceleration of health and wellness with consumers increasingly seeking nutritious solutions. With ORSL® ZERO Electrolyte Drink Mango, we wanted to offer a solution to discerning consumers who are seeking rehydration solutions with indulgence of the most-loved taste of mango. The electrolyte drink promises to help deliver rehydration with the indulgence of mango, with a benefit of zero-added sugar.'
Nagarajan Ramasubramaniam, Senior R&D Director, Kenvue, added, 'Non-Diarrheal Dehydration is often underestimated, especially among those with lifestyle-related or chronic health conditions. It can quietly impact energy levels, cognition and recovery. ORSL® ZERO Electrolyte Drink Mango is scientifically formulated to support rehydration with its blend of fluid and electrolytes while its zero added sugar profile makes it suitable for those conscious about calorie consumption.
ORSL® Zero Electrolyte Drink Mango will be available at pharmacies, self service outlets and quick commerce platforms. This launch is a reaffirmation of Kenvue's commitment to making everyday care and wellness more inclusive for millions of consumers.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nagaland Governor La Ganesan dies at 80
Nagaland Governor La Ganesan dies at 80

Time of India

time29 minutes ago

  • Time of India

Nagaland Governor La Ganesan dies at 80

Nagaland Governor La Ganesan died on Friday while undergoing treatment at a private hospital in Chennai , a Raj Bhavan official said. Independence Day 2025 Modi signals new push for tech independence with local chips Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji Subhas Chandra Bose gave India its own currency He was 80. Ganesan was undergoing treatment at the ICU of the hospital for the past few days and he died on Friday night, the Kohima Raj Bhavan PRO said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You Won't Believe What These Celebrities Studied in College Learn More On August 8, Ganesan had collapsed at his home in Chennai and sustained a head injury, sources said. He was immediately rushed to the hospital, where doctors admitted him to the ICU to undergo intensive monitoring and treatment. Live Events Ganesan was appointed the 21st governor of Nagaland on February 12, 2023 and he assumed office on February 20 that year.

PM Modi asks scientists to focus on R&D, secure patents for new drugs
PM Modi asks scientists to focus on R&D, secure patents for new drugs

Business Standard

time2 hours ago

  • Business Standard

PM Modi asks scientists to focus on R&D, secure patents for new drugs

Prime Minister Narendra Modi on Friday asked scientists and entrepreneurs to focus more on research and development (R&D) and secure patents for new drugs and medical technologies to ensure self-reliance in the pharmaceutical segment. Speaking from the Red Fort on the occasion of India's 79th Independence Day, PM Modi said that this move will ensure that India not only meets its own healthcare needs but also becomes a global hub of medical innovation. The call comes at a time when India has been lagging behind in terms of R&D spending, according to a Department of Pharmaceuticals (DoP) study paper on industry-academia linkages in the segment. It states that while a number of initiatives for industry-academic linkages in India have produced positive research results over the years, due to their sporadic nature, India's share of world researchers has remained at about 2 per cent, compared to 20 per cent in the US and China. 'An analysis of the share in R&D reveals that in India, the government contributes between 75 and 80 per cent, the private sector contributes 20 to 25 per cent, and universities contribute 3 per cent,' the paper added. In comparison, OECD countries see a 69 per cent contribution from private sector companies, followed by universities at 18 per cent, government contribution at 10 per cent, and non-profit organisations at 3 per cent. Commenting on the issues faced by the pharma industry, Kiran Mazumdar-Shaw, executive chairperson of Biocon and Biocon Biologics, told CNBC TV18 that the timeline to take a new molecule from the lab to the market is a very long process, making investments in research and innovation very risky. 'Unless we have very bold regulatory reforms that shorten this lab-to-market journey, we may not see the research investment needed for a country like India,' she added. Calling on the industry to demonstrate India's ability to lead in science, technology, and human welfare, PM Modi also urged the nation to achieve self-reliance in medicines and innovation, highlighting the country's strength as the pharmacy of the world. India currently has approximately 3,000 pharmaceutical businesses with over 10,500 manufacturing facilities, offering around 60,000 generic brands in 60 therapeutic categories. Many Indian pharmaceutical companies are now looking to jump on the generic bandwagon for off-patent molecules, while pressing on plans to develop a biosimilars pipeline post the Covid-19 pandemic. Pharma firms have gone on a generic spree after several blockbuster molecules used in diabetes medications, such as empagliflozin and dapagliflozin, went off patent in the last two years. Major blockbuster molecules that have seen several generic launches in this timeframe include empagliflozin and dapagliflozin, used in diabetes medications, which saw the prices of these drugs fall by 85 per cent in the Indian market. Similarly, companies such as Sun Pharma, Torrent, Lupin, Glenmark, and Dr Reddy's are also working on generic versions of weight loss drugs based on the blockbuster molecule semaglutide, which is expected to go off patent by March 2026. According to the DoP's study paper, more than 300 drug patents in different categories and geographies will be expiring every year during the patent cliff period of 2022 to 2032. 'The patent cliff will provide an opportunity for Indian generic companies to enter the US and other regulated markets and produce more affordable versions of those medications,' the paper added. PM flags obesity crisis in I-Day speech, calls for less oil intake PM Modi on Friday expressed concerns over obesity becoming a future crisis for India, asking people to cut down consumption of cooking oil by at least 10 per cent. India is currently projected to have the third-highest population of overweight or obese people globally, after the United States of America (USA) and China. Asking every family to take the concern seriously, the Prime Minister resolved that the country must protect itself from obesity. 'While many steps will have to be taken, I have made one small suggestion that every family should resolve that when cooking oil comes into the house, it should be 10 per cent less than usual, and its use should also be 10 per cent less. By doing so, we shall make our contribution towards winning the fight against obesity,' he stated from the ramparts of the Red Fort. According to the National Family Health Survey-5 (2019-21), 24 per cent of women and 23 per cent of men in India are overweight or obese, a sharp rise from 20.7 per cent and 18.6 per cent recorded in the NFHS-4 (2015-16), respectively. A recent Lancet study had also predicted that nearly one-third of the country's population, amounting to 218 million men and 231 million women, will be obese by 2050.

Foreign Medical Graduate Examination June 2025 result out, scorecards Aug 21
Foreign Medical Graduate Examination June 2025 result out, scorecards Aug 21

India Today

time4 hours ago

  • India Today

Foreign Medical Graduate Examination June 2025 result out, scorecards Aug 21

The National Board of Examinations in Medical Sciences (NBEMS) has announced the results of the Foreign Medical Graduate Examination (FMGE) June 2025 session on August 13. The results are now available on the official NBEMS portals, and can check their result status using their application and roll numbers. The published results are digitally signed and serve as an official notification of CONDUCT AND SCOREBOARD AVAILABILITYThe FMGE June 2025 examination took place on July 26, 2025. Alongside the result announcement, NBEMS confirmed that individual scorecards will be available for download from August 21, 2025. These scorecards will remain accessible for only six months from the date of NBEMS has clarified that the scorecard alone cannot be used to obtain registration from State Medical Councils (SMCs).Only the FMGE Pass Certificate, issued after an in-person identity and credential verification, will be accepted for this RESULTS AND VERIFICATIONThe results of five candidates have been withheld pending clarifications from the National Medical Commission or based on the outcome of the Exam Ethics Committee qualified candidates, NBEMS will distribute pass certificates in person after verifying identity and credentials. The schedule for certificate collection will be announced separately on the NBEMS prevent misuse, NBEMS has stated that SMCs will receive the results directly in a secure format. This will allow councils to verify pass certificates before granting board also stressed that eligibility checks will continue even after results are declared. If any ineligibility is detected at a later stage, the result and/or pass certificate will be TAKEAWAYS FOR CANDIDATESCheck results at NBEMS official websites using roll and application available from August 21, valid for download for six certificates require in-person sent directly to SMCs for independent will be reviewed even after results; violations can lead to FMGE is a qualifying exam for Indian citizens with foreign medical degrees to practice in India, making these updates crucial for aspiring practitioners.- Ends

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store